Studies on plasma vasopressin and the renin-angiotensin-aldosterone system in chronic obstructive lung disease. 1977

M O Farber, and S S Kiblawi, and R A Strawbridge, and G L Robertson, and M H Weinberger, and F Manfredi

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002245 Carbon Dioxide A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. Carbonic Anhydride,Anhydride, Carbonic,Dioxide, Carbon
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D001127 Arginine Vasopressin The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Argipressin,Vasopressin, Arginine,Arg-Vasopressin,Argipressin Tannate,Arg Vasopressin

Related Publications

M O Farber, and S S Kiblawi, and R A Strawbridge, and G L Robertson, and M H Weinberger, and F Manfredi
October 1989, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
M O Farber, and S S Kiblawi, and R A Strawbridge, and G L Robertson, and M H Weinberger, and F Manfredi
November 1976, Die Medizinische Welt,
M O Farber, and S S Kiblawi, and R A Strawbridge, and G L Robertson, and M H Weinberger, and F Manfredi
February 2005, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
M O Farber, and S S Kiblawi, and R A Strawbridge, and G L Robertson, and M H Weinberger, and F Manfredi
June 1989, Zhonghua yi xue za zhi,
M O Farber, and S S Kiblawi, and R A Strawbridge, and G L Robertson, and M H Weinberger, and F Manfredi
November 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
M O Farber, and S S Kiblawi, and R A Strawbridge, and G L Robertson, and M H Weinberger, and F Manfredi
December 2017, Critical care medicine,
M O Farber, and S S Kiblawi, and R A Strawbridge, and G L Robertson, and M H Weinberger, and F Manfredi
May 1991, Polskie Archiwum Medycyny Wewnetrznej,
M O Farber, and S S Kiblawi, and R A Strawbridge, and G L Robertson, and M H Weinberger, and F Manfredi
January 1983, Terapevticheskii arkhiv,
M O Farber, and S S Kiblawi, and R A Strawbridge, and G L Robertson, and M H Weinberger, and F Manfredi
March 1988, European journal of anaesthesiology,
M O Farber, and S S Kiblawi, and R A Strawbridge, and G L Robertson, and M H Weinberger, and F Manfredi
December 1983, Endocrinologia japonica,
Copied contents to your clipboard!